Brian Wolpin MD MPH

Dana-Farber Cancer Institute

Latest Videos

Dr. Brian Wolpin and colleagues discuss groundbreaking data for Daraxonrasib in mPDAC from the Phase 3 RASolute 302 Trial.

Conferences

06/18/2026

Phase 3 RASolute 302 Trial: Groundbreaking Data for Daraxonrasib in mPDAC

Brian Wolpin MD MPHRahul Gosain, MD, MBARohit Gosain, MD